Completely agreed, utDNA & other urinary biomarkers will likely be able to provide a strong go/no signal for further development but we will need RCTs to determine the relative risk/benefit trade-offs among treatments for oncologic outcomes, tolerability, and PROs
So glad you are pushing forward with this in
@SWOG , it will be a major step and landmark study for sure. Looking forward to enrolling patients on it
@UrologyMSK